首页 > 最新文献

Korean Journal of Internal Medicine最新文献

英文 中文
Impact of socioeconomic status on biologics utilization in rheumatoid arthritis: revealing inequalities and healthcare efficiency. 社会经济地位对类风湿关节炎生物制剂使用的影响:揭示不平等和医疗保健效率。
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 Epub Date: 2024-02-29 DOI: 10.3904/kjim.2023.276
Hye Won Kim, Yeon Ju Lee, You-Jung Ha, Eun Bong Lee, Yun Jong Lee, Eun Ha Kang

Background/aims: This cross-sectional study aimed to investigate biologics treatment disparities in rheumatoid arthritis (RA) patients based on socioeconomic status (SES).

Methods: Data from the KOrean Observational Study Network for Arthritis (KORONA) database were analyzed to assess various factors associated with SES, health behaviors, and biologics use. Logistic regression and structured equation modeling (SEM) were utilized for data analysis.

Results: Among 5,077 RA patients included, 393 (7.7%) patients were identified as biologics users. Within the entire cohort, 31.8% of the participants were in the low-income and low-education groups, and 39.3% of the participants were in the high-income and high-education groups. Despite the patients with low income or low education experienced higher disease activity at diagnosis, had more comorbidities, exhibited higher medication compliance, underwent more check-ups, and had more hospital admissions than their counterparts, the odds of patients with low-income receiving biologics were 34% lower (adjusted odds ratio = 0.76, 95% confidence interval: 0.60-0.96, p = 0.021) after adjustment for demographics and comorbidities. SEM and pathway analyses confirmed the negative impact of low SES on biologics use.

Conclusion: The findings suggest that SES plays a significant role in biologics use among RA patients, indicating potential healthcare inefficiencies for low SES patients. Moreover, adverse healthcare habits negatively affect biologics use in RA patients. The study highlights the importance of considering socioeconomic factors while discussing biologics use and promoting equitable access to biologics for optimal RA management.

背景/摘要这项横断面研究旨在调查类风湿关节炎(RA)患者在社会经济地位(SES)基础上的生物制剂治疗差异:研究分析了来自韩国关节炎观察研究网络(KORONA)数据库的数据,以评估与社会经济地位、健康行为和生物制剂使用相关的各种因素。数据分析采用了逻辑回归和结构方程模型(SEM):在纳入的 5077 名 RA 患者中,有 393 人(7.7%)被确认为生物制剂使用者。在整个队列中,31.8%的参与者属于低收入和低教育群体,39.3%的参与者属于高收入和高教育群体。尽管低收入或低学历患者在确诊时的疾病活动度更高、合并症更多、用药依从性更高、接受的检查更多,入院次数也比同类患者多,但在调整人口统计学和合并症后,低收入患者接受生物制剂治疗的几率比同类患者低 34%(调整后的几率比 = 0.76,95% 置信区间:0.60-0.96,p = 0.021)。SEM和路径分析证实了低社会经济地位对使用生物制剂的负面影响:研究结果表明,社会经济地位在RA患者使用生物制剂的过程中起着重要作用,这表明社会经济地位低的患者可能无法获得高效的医疗服务。此外,不良的医疗保健习惯也会对 RA 患者使用生物制剂产生负面影响。该研究强调了在讨论生物制剂的使用时考虑社会经济因素的重要性,以及促进公平获得生物制剂以优化 RA 管理的重要性。
{"title":"Impact of socioeconomic status on biologics utilization in rheumatoid arthritis: revealing inequalities and healthcare efficiency.","authors":"Hye Won Kim, Yeon Ju Lee, You-Jung Ha, Eun Bong Lee, Yun Jong Lee, Eun Ha Kang","doi":"10.3904/kjim.2023.276","DOIUrl":"10.3904/kjim.2023.276","url":null,"abstract":"<p><strong>Background/aims: </strong>This cross-sectional study aimed to investigate biologics treatment disparities in rheumatoid arthritis (RA) patients based on socioeconomic status (SES).</p><p><strong>Methods: </strong>Data from the KOrean Observational Study Network for Arthritis (KORONA) database were analyzed to assess various factors associated with SES, health behaviors, and biologics use. Logistic regression and structured equation modeling (SEM) were utilized for data analysis.</p><p><strong>Results: </strong>Among 5,077 RA patients included, 393 (7.7%) patients were identified as biologics users. Within the entire cohort, 31.8% of the participants were in the low-income and low-education groups, and 39.3% of the participants were in the high-income and high-education groups. Despite the patients with low income or low education experienced higher disease activity at diagnosis, had more comorbidities, exhibited higher medication compliance, underwent more check-ups, and had more hospital admissions than their counterparts, the odds of patients with low-income receiving biologics were 34% lower (adjusted odds ratio = 0.76, 95% confidence interval: 0.60-0.96, p = 0.021) after adjustment for demographics and comorbidities. SEM and pathway analyses confirmed the negative impact of low SES on biologics use.</p><p><strong>Conclusion: </strong>The findings suggest that SES plays a significant role in biologics use among RA patients, indicating potential healthcare inefficiencies for low SES patients. Moreover, adverse healthcare habits negatively affect biologics use in RA patients. The study highlights the importance of considering socioeconomic factors while discussing biologics use and promoting equitable access to biologics for optimal RA management.</p>","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":" ","pages":"668-679"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139991522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing and predictors of death during treatment in patients with multidrug/rifampin-resistant tuberculosis in South Korea. 韩国耐多药/利福平结核病患者在治疗期间死亡的时间和预测因素。
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 Epub Date: 2024-06-24 DOI: 10.3904/kjim.2024.029
Eunjeong Son, Hongjo Choi, Jeongha Mok, Young Ae Kang, Dawoon Jeong, Doosoo Jeon

Background/aims: This study aimed to investigate the timing and predictors of death during treatment among patients with multidrug/rifampin-resistant tuberculosis (MDR/RR-TB) in South Korea.

Methods: This was a retrospective cohort study that included MDR/RR-TB cases notified between 2011 and 2017 in South Korea.

Results: Among 7,226 MDR/RR-TB cases, 699 (9.7%) died at a median of 167 days (IQR 51-358 d) from the initiation of MDR-TB treatment. The cumulative proportion of all-cause death was 35.5% at 90 days and 52.8% at 180 days from treatment initiation. TB-related deaths occurred at a median of 133 days (IQR 32-366 d), which was significantly earlier than the median of 184 days (IQR 68-356 d) for non-TB-related deaths (p = 0.002). In a multivariate analysis, older age was the factor most strongly associated with death, with those aged ≥ 75 years being 68 times more likely to die (aHR 68.11, 95% CI 21.75-213.26), compared those aged ≤ 24 years. In addition, male sex, comorbidities (cancer, human immunodeficiency virus, and end stage renal disease), the lowest household income class, and TB-specific factors (previous history of TB treatment, smear positivity, and fluoroquinolone resistance) were identified as independent predictors of all-cause death.

Conclusion: This nationwide study highlights increased deaths during the intensive phase and identifies high-risk groups including older people and those with comorbidities or socioeconomic vulnerabilities. An integrated and comprehensive strategy is required to reduce mortality in patients with MDR/RR-TB, particularly focusing on the early stages of treatment and target populations.

背景/目的本研究旨在调查韩国耐多药/利福平肺结核(MDR/RR-TB)患者在治疗期间死亡的时间和预测因素:这是一项回顾性队列研究,纳入了2011年至2017年间韩国通报的MDR/RR-TB病例:在7226例MDR/RR-TB病例中,有699例(9.7%)在开始接受MDR-TB治疗后的167天(IQR为51-358天)内死亡。在开始治疗 90 天和 180 天时,全因死亡的累计比例分别为 35.5%和 52.8%。肺结核相关死亡的中位数为 133 天(IQR 32-366 d),明显早于非肺结核相关死亡的中位数 184 天(IQR 68-356 d)(p = 0.002)。在多变量分析中,年龄较大是与死亡关系最密切的因素,与年龄≤24岁的人相比,年龄≥75岁的人死亡的可能性要高出68倍(aHR 68.11,95% CI 21.75-213.26)。此外,男性性别、合并症(癌症、人类免疫缺陷病毒和终末期肾病)、最低家庭收入等级和结核病特异性因素(既往结核病治疗史、涂片阳性和氟喹诺酮耐药性)被确定为全因死亡的独立预测因素:这项全国性研究强调了强化阶段死亡人数的增加,并确定了包括老年人、合并症患者或社会经济弱势群体在内的高危人群。需要采取综合全面的策略来降低耐多药/耐药结核病患者的死亡率,尤其要关注治疗的早期阶段和目标人群。
{"title":"Timing and predictors of death during treatment in patients with multidrug/rifampin-resistant tuberculosis in South Korea.","authors":"Eunjeong Son, Hongjo Choi, Jeongha Mok, Young Ae Kang, Dawoon Jeong, Doosoo Jeon","doi":"10.3904/kjim.2024.029","DOIUrl":"10.3904/kjim.2024.029","url":null,"abstract":"<p><strong>Background/aims: </strong>This study aimed to investigate the timing and predictors of death during treatment among patients with multidrug/rifampin-resistant tuberculosis (MDR/RR-TB) in South Korea.</p><p><strong>Methods: </strong>This was a retrospective cohort study that included MDR/RR-TB cases notified between 2011 and 2017 in South Korea.</p><p><strong>Results: </strong>Among 7,226 MDR/RR-TB cases, 699 (9.7%) died at a median of 167 days (IQR 51-358 d) from the initiation of MDR-TB treatment. The cumulative proportion of all-cause death was 35.5% at 90 days and 52.8% at 180 days from treatment initiation. TB-related deaths occurred at a median of 133 days (IQR 32-366 d), which was significantly earlier than the median of 184 days (IQR 68-356 d) for non-TB-related deaths (p = 0.002). In a multivariate analysis, older age was the factor most strongly associated with death, with those aged ≥ 75 years being 68 times more likely to die (aHR 68.11, 95% CI 21.75-213.26), compared those aged ≤ 24 years. In addition, male sex, comorbidities (cancer, human immunodeficiency virus, and end stage renal disease), the lowest household income class, and TB-specific factors (previous history of TB treatment, smear positivity, and fluoroquinolone resistance) were identified as independent predictors of all-cause death.</p><p><strong>Conclusion: </strong>This nationwide study highlights increased deaths during the intensive phase and identifies high-risk groups including older people and those with comorbidities or socioeconomic vulnerabilities. An integrated and comprehensive strategy is required to reduce mortality in patients with MDR/RR-TB, particularly focusing on the early stages of treatment and target populations.</p>","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":" ","pages":"640-649"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Staphylococcal enterotoxin B sensitization in eosinophilic asthma. 嗜酸性粒细胞性哮喘中的葡萄球菌肠毒素 B 致敏。
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 DOI: 10.3904/kjim.2024.216
Gyu-Young Hur
{"title":"Staphylococcal enterotoxin B sensitization in eosinophilic asthma.","authors":"Gyu-Young Hur","doi":"10.3904/kjim.2024.216","DOIUrl":"10.3904/kjim.2024.216","url":null,"abstract":"","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":"39 4","pages":"543-544"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies to improve screening colonoscopy quality for the prevention of colorectal cancer. 提高结肠镜筛查质量以预防结肠直肠癌的策略。
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 Epub Date: 2024-01-22 DOI: 10.3904/kjim.2023.334
Joo Hye Song, Eun Ran Kim

The incidence and mortality of colorectal cancer (CRC) have decreased through regular screening colonoscopy, surveillance, and endoscopic treatment. However, CRC can still be diagnosed after negative colonoscopy. Such CRC is called interval CRC and accounts for 1.8-9.0% of all CRC cases. Most cases of interval CRC originate from missed lesions and incompletely resected lesions. Interval CRC can be minimized by improving the quality of colonoscopy. This has led to a growing interest in and demand for high-quality colonoscopy. It is important to reduce the risk of CRC and its associated mortality by improving the quality of colonoscopy. In this review article, we provide an overview of colonoscopy quality indicators, including bowel preparation adequacy, the cecal intubation rate, the adenoma detection rate, the colonoscopy withdrawal time, appropriate polypectomy, and complication of the procedure. Because colonoscopy is a highly endoscopist-dependent procedure, colonoscopists should be well-acquainted with quality indicators and strive to apply them in daily clinical practice for the prevention of CRC.

通过定期进行结肠镜筛查、监测和内镜治疗,结肠直肠癌(CRC)的发病率和死亡率都有所下降。然而,结肠镜检查阴性后仍可诊断出 CRC。这种 CRC 被称为间期 CRC,占所有 CRC 病例的 1.8-9.0%。大多数间歇性 CRC 病例都是由漏诊病灶和未完全切除病灶引起的。通过提高结肠镜检查的质量,可以最大限度地减少间隔期 CRC。因此,人们对高质量结肠镜检查的兴趣和需求与日俱增。通过提高结肠镜检查质量来降低 CRC 风险及其相关死亡率非常重要。在这篇综述文章中,我们概述了结肠镜检查的质量指标,包括肠道准备是否充分、盲肠插管率、腺瘤检出率、结肠镜检查退出时间、适当的息肉切除术以及手术并发症。由于结肠镜检查是一项高度依赖内镜医师的手术,因此结肠镜医师应熟知质量指标,并努力将其应用于日常临床实践,以预防 CRC。
{"title":"Strategies to improve screening colonoscopy quality for the prevention of colorectal cancer.","authors":"Joo Hye Song, Eun Ran Kim","doi":"10.3904/kjim.2023.334","DOIUrl":"10.3904/kjim.2023.334","url":null,"abstract":"<p><p>The incidence and mortality of colorectal cancer (CRC) have decreased through regular screening colonoscopy, surveillance, and endoscopic treatment. However, CRC can still be diagnosed after negative colonoscopy. Such CRC is called interval CRC and accounts for 1.8-9.0% of all CRC cases. Most cases of interval CRC originate from missed lesions and incompletely resected lesions. Interval CRC can be minimized by improving the quality of colonoscopy. This has led to a growing interest in and demand for high-quality colonoscopy. It is important to reduce the risk of CRC and its associated mortality by improving the quality of colonoscopy. In this review article, we provide an overview of colonoscopy quality indicators, including bowel preparation adequacy, the cecal intubation rate, the adenoma detection rate, the colonoscopy withdrawal time, appropriate polypectomy, and complication of the procedure. Because colonoscopy is a highly endoscopist-dependent procedure, colonoscopists should be well-acquainted with quality indicators and strive to apply them in daily clinical practice for the prevention of CRC.</p>","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":" ","pages":"547-554"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139513988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between specific IgE to staphylococcal enterotoxin B and the eosinophilic phenotype of asthma. 葡萄球菌肠毒素 B 的特异性 IgE 与哮喘的嗜酸性表型之间的关系。
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 DOI: 10.3904/kjim.2024.003
Soyoon Sim, Youngwoo Choi, Eun-Mi Yang, Hae-Sim Park

Background/aims: Sensitization to staphylococcal superantigens (SAgs) could contribute to asthma severity. However, its relevance with eosinophilic phenotype has not yet been clarified. This study aimed to investigate associations between serum specific IgE levels to SAg and eosinophilic airway inflammation in adult asthmatics.

Methods: The serum specific IgE levels to 3 SAgs, including staphylococcal enterotoxin A (SEA) and B (SEB), and toxic shock syndrome toxin-1 (TSST-1) were measured by ImmunoCAP in 230 adult asthmatic patients and 50 healthy controls (HCs). Clinical characteristics and laboratory parameters, including serum total/free IgE, and 2 eosinophil-activation markers, eosinophil cationic protein (ECP), and eosinophil-derived neurotoxin (EDN), were analyzed according to blood eosinophil counts (BEC; 150 cells/μL) and serum specific IgE levels to 3 SAgs (0.35 kU/L).

Results: Asthmatic patients showed higher serum specific IgE levels to 3 SAgs than HCs (p < 0.05 for all). The serum total/clinfree IgE levels were significantly higher in asthmatics with positive IgE responses to 3 SAgs than those without (p < 0.05 for all). There were no significant differences in clinical parameters including age, asthma severity, comorbidities, or smoking according to IgE responses to 3 SAgs. Patients with positive IgE responses to SEB (not to SEA/TSST-1) had higher serum specific IgE levels to house dust mites and ECP/EDN as well as higher BEC with positive correlations between serum SEB-specific IgE levels and BEC/ECP/EDN (p < 0.05 for all).

Conclusion: These findings suggest that serum SEB-specific IgE levels could contribute to eosinophil activation as well as IgE production in adult asthma.

背景/目的:对葡萄球菌超抗原(SAgs)的过敏可能会导致哮喘的严重程度。然而,其与嗜酸性粒细胞表型的相关性尚未明确。本研究旨在调查成年哮喘患者血清中SAg特异性IgE水平与嗜酸性粒细胞气道炎症之间的关系:方法:采用免疫细胞分析仪(ImmunoCAP)测定了 230 名成年哮喘患者和 50 名健康对照组(HCs)血清中 3 种 SAg(包括葡萄球菌肠毒素 A(SEA)和 B(SEB)以及中毒性休克综合征毒素-1(TSST-1))的特异性 IgE 水平。根据血液嗜酸性粒细胞计数(BEC;150 cells/μL)和 3 种 SAgs 血清特异性 IgE 水平(0.35 kU/L)分析了临床特征和实验室参数,包括血清总 IgE/游离 IgE 和 2 种嗜酸性粒细胞活化标记物、嗜酸性粒细胞阳离子蛋白(ECP)和嗜酸性粒细胞衍生神经毒素(EDN):哮喘患者血清中 3 种嗜酸性粒细胞的特异性 IgE 水平高于嗜酸性粒细胞(P < 0.05)。对 3 种 SAgs 有阳性 IgE 反应的哮喘患者的血清总 IgE 水平/游离 IgE 水平明显高于没有阳性 IgE 反应的哮喘患者(P < 0.05)。临床参数(包括年龄、哮喘严重程度、合并症或吸烟)与 3 种 SAg 的 IgE 反应无明显差异。对SEB(而非SEA/TSST-1)有阳性IgE反应的患者,其血清中对屋尘螨和ECP/EDN的特异性IgE水平较高,BEC也较高,血清中SEB特异性IgE水平与BEC/ECP/EDN之间呈正相关(均为P < 0.05):这些研究结果表明,血清SEB特异性IgE水平可能有助于嗜酸性粒细胞的活化以及成人哮喘患者IgE的产生。
{"title":"Association between specific IgE to staphylococcal enterotoxin B and the eosinophilic phenotype of asthma.","authors":"Soyoon Sim, Youngwoo Choi, Eun-Mi Yang, Hae-Sim Park","doi":"10.3904/kjim.2024.003","DOIUrl":"10.3904/kjim.2024.003","url":null,"abstract":"<p><strong>Background/aims: </strong>Sensitization to staphylococcal superantigens (SAgs) could contribute to asthma severity. However, its relevance with eosinophilic phenotype has not yet been clarified. This study aimed to investigate associations between serum specific IgE levels to SAg and eosinophilic airway inflammation in adult asthmatics.</p><p><strong>Methods: </strong>The serum specific IgE levels to 3 SAgs, including staphylococcal enterotoxin A (SEA) and B (SEB), and toxic shock syndrome toxin-1 (TSST-1) were measured by ImmunoCAP in 230 adult asthmatic patients and 50 healthy controls (HCs). Clinical characteristics and laboratory parameters, including serum total/free IgE, and 2 eosinophil-activation markers, eosinophil cationic protein (ECP), and eosinophil-derived neurotoxin (EDN), were analyzed according to blood eosinophil counts (BEC; 150 cells/μL) and serum specific IgE levels to 3 SAgs (0.35 kU/L).</p><p><strong>Results: </strong>Asthmatic patients showed higher serum specific IgE levels to 3 SAgs than HCs (p < 0.05 for all). The serum total/clinfree IgE levels were significantly higher in asthmatics with positive IgE responses to 3 SAgs than those without (p < 0.05 for all). There were no significant differences in clinical parameters including age, asthma severity, comorbidities, or smoking according to IgE responses to 3 SAgs. Patients with positive IgE responses to SEB (not to SEA/TSST-1) had higher serum specific IgE levels to house dust mites and ECP/EDN as well as higher BEC with positive correlations between serum SEB-specific IgE levels and BEC/ECP/EDN (p < 0.05 for all).</p><p><strong>Conclusion: </strong>These findings suggest that serum SEB-specific IgE levels could contribute to eosinophil activation as well as IgE production in adult asthma.</p>","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":"39 4","pages":"659-667"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236811/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of statin use on serum creatinine phosphokinase levels in normal thyroid function. 他汀类药物对甲状腺功能正常者血清肌酸磷酸激酶水平的影响
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 Epub Date: 2024-06-24 DOI: 10.3904/kjim.2024.085
Jeonghoon Ha, Joonyub Lee, Jin Yu, Hakyoung Park, Jiwon Shinn, Seung-Hwan Lee, Jae-Hyoung Cho, Hun-Sung Kim

Background/aims: Statins are common lipid-lowering agents used in dyslipidemia. However, they increase serum creatinine phosphokinase (CPK) levels. Currently, there are no studies on the effect of thyroid-stimulating hormone (TSH) levels on CPK levels after statin administration. Therefore, this study aimed to investigate CPK level alterations after statin administration according to TSH quartiles in participants with euthyroidism.

Methods: This retrospective analysis included 25,047 patients with euthyroidism. CPK levels were measured before and 6 months after statin administration. Normal TSH levels were divided into four quartiles, and the CPK levels and proportions of patients with normal CPK levels after statin administration for each TSH quartile were evaluated.

Results: The baseline CPK level was significantly higher in the lowest TSH quartile (Q1) compared to the other quartiles but decreased after statin administration. Thus, the difference between the CPK levels and the other quartile groups was not significant. The proportion of patients with normal CPK levels was also significantly lowest in Q1 before statin administration; however, no significant difference was noted in the ratio among each group after statin administration. These findings were consistent with the findings of the analysis according to statin intensity.

Conclusion: In patients in the lowest TSH quartile of the normal TSH range, the CPK level decreased, and the proportion of normal CPK levels increased significantly after statin administration. However, similar changes were not observed in other TSH quartiles. Therefore, further studies are required to mechanistically confirm these conclusions.

背景/目的:他汀类药物是治疗血脂异常的常用降脂药。然而,他汀类药物会增加血清肌酸磷酸激酶(CPK)水平。目前,还没有关于他汀类药物用药后促甲状腺激素(TSH)水平对 CPK 水平影响的研究。因此,本研究旨在调查甲状腺功能亢进者服用他汀类药物后 CPK 水平随 TSH 四分位数的变化情况:这项回顾性分析包括 25047 名甲状腺功能亢进症患者。在他汀类药物用药前和用药 6 个月后测量 CPK 水平。将正常 TSH 水平分为四个四分位数,评估每个 TSH 四分位数的 CPK 水平以及服用他汀类药物后 CPK 水平正常的患者比例:结果:TSH 最低四分位数(Q1)的 CPK 基线水平明显高于其他四分位数,但服用他汀类药物后 CPK 水平下降。因此,CPK 水平与其他四分位组之间的差异并不显著。在服用他汀类药物前,CPK 水平正常的患者比例在 Q1 组中也明显最低;但在服用他汀类药物后,各组之间的比例没有明显差异。这些结果与根据他汀类药物强度进行的分析结果一致:结论:服用他汀类药物后,正常 TSH 范围内 TSH 最低四分位数患者的 CPK 水平下降,CPK 水平正常的比例显著增加。然而,在其他 TSH 四分位数中并未观察到类似的变化。因此,还需要进一步的研究来从机理上证实这些结论。
{"title":"Effects of statin use on serum creatinine phosphokinase levels in normal thyroid function.","authors":"Jeonghoon Ha, Joonyub Lee, Jin Yu, Hakyoung Park, Jiwon Shinn, Seung-Hwan Lee, Jae-Hyoung Cho, Hun-Sung Kim","doi":"10.3904/kjim.2024.085","DOIUrl":"10.3904/kjim.2024.085","url":null,"abstract":"<p><strong>Background/aims: </strong>Statins are common lipid-lowering agents used in dyslipidemia. However, they increase serum creatinine phosphokinase (CPK) levels. Currently, there are no studies on the effect of thyroid-stimulating hormone (TSH) levels on CPK levels after statin administration. Therefore, this study aimed to investigate CPK level alterations after statin administration according to TSH quartiles in participants with euthyroidism.</p><p><strong>Methods: </strong>This retrospective analysis included 25,047 patients with euthyroidism. CPK levels were measured before and 6 months after statin administration. Normal TSH levels were divided into four quartiles, and the CPK levels and proportions of patients with normal CPK levels after statin administration for each TSH quartile were evaluated.</p><p><strong>Results: </strong>The baseline CPK level was significantly higher in the lowest TSH quartile (Q1) compared to the other quartiles but decreased after statin administration. Thus, the difference between the CPK levels and the other quartile groups was not significant. The proportion of patients with normal CPK levels was also significantly lowest in Q1 before statin administration; however, no significant difference was noted in the ratio among each group after statin administration. These findings were consistent with the findings of the analysis according to statin intensity.</p><p><strong>Conclusion: </strong>In patients in the lowest TSH quartile of the normal TSH range, the CPK level decreased, and the proportion of normal CPK levels increased significantly after statin administration. However, similar changes were not observed in other TSH quartiles. Therefore, further studies are required to mechanistically confirm these conclusions.</p>","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":" ","pages":"650-658"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increasing correlation between oral and gastric microbiota during gastric carcinogenesis. 在胃癌发生过程中,口腔和胃微生物群之间的相关性不断增强。
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 Epub Date: 2024-06-24 DOI: 10.3904/kjim.2023.490
Hee Sang You, Jae Yong Park, Hochan Seo, Beom Jin Kim, Jae Gyu Kim

Background/aims: Recent research has increasingly focused on the role of the gastric microbiome in the development of gastric cancer. We aimed to investigate the changes in the microbiome during gastric carcinogenesis in structural and functional aspects, with a specific focus on the association between oral and gastric microbiomes.

Methods: We collected saliva, gastric juice, and gastric tissue samples from 141 patients at different stages of gastric carcinogenesis and processed them for microbiome analysis using 16S rRNA gene profiling. The alpha and beta diversities were analyzed, and the differences in microbiome composition and function profiles were analyzed among the groups, as well as the correlation between changes in the oral and gastric microbiomes during carcinogenesis.

Results: We observed significant differences in microbial diversity and composition between the disease and control groups, primarily in the gastric juice. Specific bacterial strains, including Schaalia odontolytica, Streptococcus cristatus, and Peptostreptococcus stomatis, showed a significant increase in abundance in the gastric juice in the low-grade dysplasia and gastric cancer groups. Notably, the correlation between the oral and gastric microbiota compositions, increased as the disease progressed. Predictive analysis of the metagenomic functional profiles revealed changes in functional pathways that may be associated with carcinogenesis (ABC transport and two-component systems).

Conclusion: During gastric carcinogenesis, the abundance of oral commensals associated with cancer increased in the stomach. The similarity in microbial composition between the stomach and oral cavity also increased, implying a potential role of oral-gastric bacterial interactions in gastric cancer development.

背景/目的:最近的研究越来越关注胃微生物组在胃癌发生中的作用。我们旨在研究胃癌发生过程中微生物组在结构和功能方面的变化,特别关注口腔和胃微生物组之间的关联:方法:我们收集了 141 位处于胃癌发生不同阶段的患者的唾液、胃液和胃组织样本,并使用 16S rRNA 基因图谱对其进行微生物组分析。分析了α和β多样性,分析了不同组间微生物组组成和功能谱的差异,以及癌变过程中口腔和胃微生物组变化之间的相关性:结果:我们观察到疾病组和对照组的微生物多样性和组成存在明显差异,主要是在胃液中。特定细菌菌株,包括Schaalia odontolytica、皱褶链球菌和口腔普氏链球菌,在低度发育不良组和胃癌组的胃液中含量显著增加。值得注意的是,口腔微生物群和胃微生物群组成之间的相关性随着病情的发展而增加。对元基因组功能图谱的预测分析表明,可能与癌变有关的功能通路(ABC转运和双组分系统)发生了变化:结论:在胃癌发生过程中,胃中与癌症相关的口腔共生菌数量增加。结论:在胃癌发生过程中,胃中与癌症相关的口腔共生菌的数量增加了,胃和口腔中微生物组成的相似性也增加了,这意味着口腔-胃细菌相互作用在胃癌发生过程中可能起了作用。
{"title":"Increasing correlation between oral and gastric microbiota during gastric carcinogenesis.","authors":"Hee Sang You, Jae Yong Park, Hochan Seo, Beom Jin Kim, Jae Gyu Kim","doi":"10.3904/kjim.2023.490","DOIUrl":"10.3904/kjim.2023.490","url":null,"abstract":"<p><strong>Background/aims: </strong>Recent research has increasingly focused on the role of the gastric microbiome in the development of gastric cancer. We aimed to investigate the changes in the microbiome during gastric carcinogenesis in structural and functional aspects, with a specific focus on the association between oral and gastric microbiomes.</p><p><strong>Methods: </strong>We collected saliva, gastric juice, and gastric tissue samples from 141 patients at different stages of gastric carcinogenesis and processed them for microbiome analysis using 16S rRNA gene profiling. The alpha and beta diversities were analyzed, and the differences in microbiome composition and function profiles were analyzed among the groups, as well as the correlation between changes in the oral and gastric microbiomes during carcinogenesis.</p><p><strong>Results: </strong>We observed significant differences in microbial diversity and composition between the disease and control groups, primarily in the gastric juice. Specific bacterial strains, including Schaalia odontolytica, Streptococcus cristatus, and Peptostreptococcus stomatis, showed a significant increase in abundance in the gastric juice in the low-grade dysplasia and gastric cancer groups. Notably, the correlation between the oral and gastric microbiota compositions, increased as the disease progressed. Predictive analysis of the metagenomic functional profiles revealed changes in functional pathways that may be associated with carcinogenesis (ABC transport and two-component systems).</p><p><strong>Conclusion: </strong>During gastric carcinogenesis, the abundance of oral commensals associated with cancer increased in the stomach. The similarity in microbial composition between the stomach and oral cavity also increased, implying a potential role of oral-gastric bacterial interactions in gastric cancer development.</p>","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":" ","pages":"590-602"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary peritoneal carcinoma presented with abdominal pain in patient with kidney transplantation. 肾移植患者腹痛并发原发性腹膜癌。
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 Epub Date: 2024-04-29 DOI: 10.3904/kjim.2023.254
Eunmi Jo, Sang Heon Song
{"title":"Primary peritoneal carcinoma presented with abdominal pain in patient with kidney transplantation.","authors":"Eunmi Jo, Sang Heon Song","doi":"10.3904/kjim.2023.254","DOIUrl":"10.3904/kjim.2023.254","url":null,"abstract":"","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":" ","pages":"693-694"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140858970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approaches and considerations in the endoscopic treatment of T1 colorectal cancer. T1 结直肠癌的内窥镜治疗方法和注意事项。
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 Epub Date: 2024-05-14 DOI: 10.3904/kjim.2023.487
Yunho Jung

The detection of early colorectal cancer (CRC) is increasing through the implementation of screening programs. This increased detection enhances the likelihood of minimally invasive surgery and significantly lowers the risk of recurrence, thereby improving patient survival and reducing mortality rates. T1 CRC, the earliest stage, is treated endoscopically in cases with a low risk of lymph node metastasis (LNM). The advantages of endoscopic treatment compared with surgery include minimal invasiveness and limited tissue disruption, which reduce morbidity and mortality, preserve bowel function to avoid colectomy, accelerate recovery, and improve cost-effectiveness. However, T1 CRC has a risk of LNM. Thus, selection of the appropriate treatment between endoscopic treatment and surgery, while avoiding overtreatment, is challenging considering the potential for complete resection, LNM, and recurrence risk.

通过实施筛查计划,早期结直肠癌(CRC)的检出率不断提高。检测率的提高增加了微创手术的可能性,并大大降低了复发风险,从而提高了患者的生存率并降低了死亡率。对于淋巴结转移(LNM)风险较低的 T1 CRC(最早的阶段)病例,可通过内窥镜进行治疗。与外科手术相比,内镜治疗的优势在于微创和组织破坏有限,可降低发病率和死亡率,保留肠道功能以避免结肠切除术,加快康复,提高成本效益。然而,T1 CRC 有发生 LNM 的风险。因此,考虑到完全切除的可能性、LNM 和复发风险,在内镜治疗和手术治疗之间选择合适的治疗方法,同时避免过度治疗,是一项具有挑战性的工作。
{"title":"Approaches and considerations in the endoscopic treatment of T1 colorectal cancer.","authors":"Yunho Jung","doi":"10.3904/kjim.2023.487","DOIUrl":"10.3904/kjim.2023.487","url":null,"abstract":"<p><p>The detection of early colorectal cancer (CRC) is increasing through the implementation of screening programs. This increased detection enhances the likelihood of minimally invasive surgery and significantly lowers the risk of recurrence, thereby improving patient survival and reducing mortality rates. T1 CRC, the earliest stage, is treated endoscopically in cases with a low risk of lymph node metastasis (LNM). The advantages of endoscopic treatment compared with surgery include minimal invasiveness and limited tissue disruption, which reduce morbidity and mortality, preserve bowel function to avoid colectomy, accelerate recovery, and improve cost-effectiveness. However, T1 CRC has a risk of LNM. Thus, selection of the appropriate treatment between endoscopic treatment and surgery, while avoiding overtreatment, is challenging considering the potential for complete resection, LNM, and recurrence risk.</p>","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":" ","pages":"563-576"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimated pulse wave velocity as a forefront indicator of developing metabolic syndrome in Korean adults. 估计脉搏波速度是韩国成年人患代谢综合征的前沿指标。
IF 2.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-01 Epub Date: 2024-06-24 DOI: 10.3904/kjim.2024.015
Hyun-Jin Kim, Byung Sik Kim, Dong Wook Kim, Jeong-Hun Shin

Background/aims: The predictive value of the estimated pulse wave velocity (ePWV) for the development of metabolic syndrome has not yet been extensively explored. This study aimed to fill this gap by evaluating ePWV as a potential predictor of metabolic syndrome development in middle-aged Korean adults.

Methods: Using prospective data obtained from the Ansan-Ansung cohort database, participants without metabolic syndrome at baseline were studied. ePWV was calculated using specific equations based on age and blood pressure. The primary outcome was the incidence of metabolic syndrome during a median follow-up period of 187 months.

Results: Among the 6,186 participants, 2,726 (44.1%) developed metabolic syndrome during the follow-up period. ePWV methvalues were categorized into tertiles to assess their predictive value for the development of metabolic syndrome. An ePWV cut-off of 7.407 m/s was identified as a predictor of metabolic syndrome development, with a sensitivity of 0.743 and a specificity of 0.464. Participants exceeding this cut-off, especially those in the third tertile (8.77-14.63 m/s), had a notably higher risk of developing metabolic syndrome. Specifically, the third tertile exhibited a 52.8% cumulative incidence compared with 30.8% in the first tertile. After adjustments, those in the third tertile faced a 1.530-fold increased risk of metabolic syndrome (95% confidence interval, 1.330-1.761).

Conclusion: ePWV is a significant predictor of the development of metabolic syndrome. This finding underscores the potential of ePWV as a cardiometabolic risk assessment tool and can thus provide useful information for primary prevention strategies.

背景/目的:估计脉搏波速度(ePWV)对代谢综合征的预测价值尚未得到广泛探讨。本研究旨在通过评估 ePWV 作为韩国中年人代谢综合征发病的潜在预测指标来填补这一空白:利用从安山-安城队列数据库中获得的前瞻性数据,对基线时未患有代谢综合征的参与者进行了研究。主要结果是在 187 个月的中位随访期内代谢综合征的发病率:在 6,186 名参与者中,2,726 人(44.1%)在随访期间患上了代谢综合征。ePWV 方法值被分为三等分,以评估其对代谢综合征发病的预测价值。ePWV 临界值为 7.407 m/s,可预测代谢综合征的发生,灵敏度为 0.743,特异度为 0.464。超过这一临界值的参与者,尤其是处于第三三分位数(8.77-14.63 m/s)的参与者,患代谢综合征的风险明显更高。具体来说,第三分层的累积发病率为 52.8%,而第一分层为 30.8%。结论:ePWV 是代谢综合征发病的重要预测因素。这一发现强调了 ePWV 作为心脏代谢风险评估工具的潜力,从而可为一级预防策略提供有用的信息。
{"title":"Estimated pulse wave velocity as a forefront indicator of developing metabolic syndrome in Korean adults.","authors":"Hyun-Jin Kim, Byung Sik Kim, Dong Wook Kim, Jeong-Hun Shin","doi":"10.3904/kjim.2024.015","DOIUrl":"10.3904/kjim.2024.015","url":null,"abstract":"<p><strong>Background/aims: </strong>The predictive value of the estimated pulse wave velocity (ePWV) for the development of metabolic syndrome has not yet been extensively explored. This study aimed to fill this gap by evaluating ePWV as a potential predictor of metabolic syndrome development in middle-aged Korean adults.</p><p><strong>Methods: </strong>Using prospective data obtained from the Ansan-Ansung cohort database, participants without metabolic syndrome at baseline were studied. ePWV was calculated using specific equations based on age and blood pressure. The primary outcome was the incidence of metabolic syndrome during a median follow-up period of 187 months.</p><p><strong>Results: </strong>Among the 6,186 participants, 2,726 (44.1%) developed metabolic syndrome during the follow-up period. ePWV methvalues were categorized into tertiles to assess their predictive value for the development of metabolic syndrome. An ePWV cut-off of 7.407 m/s was identified as a predictor of metabolic syndrome development, with a sensitivity of 0.743 and a specificity of 0.464. Participants exceeding this cut-off, especially those in the third tertile (8.77-14.63 m/s), had a notably higher risk of developing metabolic syndrome. Specifically, the third tertile exhibited a 52.8% cumulative incidence compared with 30.8% in the first tertile. After adjustments, those in the third tertile faced a 1.530-fold increased risk of metabolic syndrome (95% confidence interval, 1.330-1.761).</p><p><strong>Conclusion: </strong>ePWV is a significant predictor of the development of metabolic syndrome. This finding underscores the potential of ePWV as a cardiometabolic risk assessment tool and can thus provide useful information for primary prevention strategies.</p>","PeriodicalId":48785,"journal":{"name":"Korean Journal of Internal Medicine","volume":" ","pages":"612-624"},"PeriodicalIF":2.2,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236817/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Korean Journal of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1